Santos, Yasmin da Silva 
; Pagni, Roberta Liberato ; Gamon, Thaís Helena Martins; Azevedo, Marcela Santiago Pacheco de ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Luvizotto, Maria Cecília Rui; Ackerman, Hans Christian; Marinho, Claudio Romero Farias ; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina
Source: International Journal of Molecular Sciences. Unidades: ICB, FCF
Subjects: COVID-19, CAMUNDONGOS, ANTAGONISMO DE DROGAS, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, v. 26, p. 1-18 art.7663, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26167663. Acesso em: 08 out. 2025.APA
Santos, Y. da S., Pagni, R. L., Gamon, T. H. M., Azevedo, M. S. P. de, Darido, M. L. G., Oliveira, D. B. L. de, et al. (2025). Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, 26, 1-18 art.7663. doi:10.3390/ijms26167663NLM
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-18 art.7663.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3390/ijms26167663Vancouver
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-18 art.7663.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3390/ijms26167663
